Cardiovascular & Soft Tissue Repair Patches Market (By Application: Vascular Repair & Reconstruction, Cardiac Repair, Pericardial Repair, Soft Tissue repair, Dural Repair; By Raw Material: ePTFE, Biomaterial and Tissue Engineered Material, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Name: Cardiovascular & Soft Tissue Repair Patches Market (By Application: Vascular Repair & Reconstruction, Cardiac Repair, Pericardial Repair, Soft Tissue repair, Dural Repair; By Raw Material: ePTFE, Biomaterial and Tissue Engineered Material, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026
Creator: Acumen Research and Consulting
Published: Apr 2019
License: https://www.acumenresearchandconsulting.com/privacy-policy

Published : Apr 2019

Report ID: ARC1297

Pages : 160

Format : Cardiovascular & Soft Tissue Repair Patches Market (By Application: Vascular Repair & Reconstruction, Cardiac Repair, Pericardial Repair, Soft Tissue repair, Dural Repair; By Raw Material: ePTFE, Biomaterial and Tissue Engineered Material, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Summary Table of Content Customization Download Sample Infographics

Introduction

The report provides analysis of global Cardiovascular & Soft Tissue Repair Patches market for the period 2016-2026, wherein 2019 to 2026 is the forecast period and 2017 is considered as the base year. According to Acumen Research and Consulting, the global Cardiovascular & Soft Tissue Repair Patches market is expected to grow at noteworthy CAGR around 8 % throughout the forecast period and reach around US$ 6 billion by 2026, The growing application and prevalence of heart defects such as atrial septal and ventricular septal defects in medical procedures and sports wounds are a factor driving demand. Some of these factors drive demand.

Market Dynamics

Heart conditions have been closely followed by heart stroke, which is the leading cause of death in the US. An estimated 85.6 million in the U.S. live with high blood pressure, heart attack, stroke, and cardiovascular diseases. These statistics are highly relevant as the leading cause of infant deaths around the world is identified as congenital heart defects. In the later stages of their life the patients will develop serious complications if these congenital defects are not treated or detectable at a young age.

Increasing use of patches are also a major driver for ePTFE and bovine repairs, for repairing hernias and soft tissues. Different types of hernias exist, such as hernias incisional, femoral, umbilical, paraumbilic, etc. Heavy lifting weight, abdominal intervention, chronic cough, constipation of as cites (fluid in the abdomen), and other conditions leading to increased pressure in the inner abdomen are key risk factors for hernia. Congenital diaphragmatic hernia is also one of the biggest causes of infant mortality. The rate of survival in the United States is nearly 50 percent for every 1 in 2,500 newborns and children diagnosed with CDH. In addition, the recurrence of a hernia following treatment is quite possible. The inguinal hernia has a recurrence rate of almost 2% and a recurrence rate of nearly 10-20%. These conditions are anticipated in the next seven years to substantially boost market growth.

Regional Snapshots

The overall revenue share of Asia Pacific dominated in 2014 by more than 59 percent. A large population basis prone to different cardiovascular and abdominal diseases that require surgical procedures is a key factor attributable to its large proportion. Furthermore, the constant improvement of health infrastructure and the high penetration of such patches are anticipated to boost market growth in economies like Japan, China, India and Australia.

Market Segmentation

Cardiovascular & Soft Tissue Repair Patches Market by Application

Vascular Repair & Reconstruction
Cardiac Repair
Pericardial Repair
Soft Tissue repair
Dural Repair

Cardiovascular & Soft Tissue Repair Patches Market by Raw Material

ePTFE
Biomaterial and Tissue Engineered Material
Others

Global Cardiovascular & Soft Tissue Repair Patches Market, by Geography

North America

U.S.
Canada
Mexico

Europe

UK
Germany
France
Rest of Europe

Asia-Pacific

China
Japan
India
Australia
Rest of Asia-Pacific

Latin America

Brazil
Chile
Rest of Latin America

Middle East and Africa (MEA)

South Africa
Saudi Arabia
Rest of MEA

The market research study on “Cardiovascular & Soft Tissue Repair Patches Market (By Application: Vascular Repair & Reconstruction, Cardiac Repair, Pericardial Repair, Soft Tissue repair, Dural Repair; By Raw Material: ePTFE, Biomaterial and Tissue Engineered Material, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Cardiovascular & Soft Tissue Repair Patches market segments with market dynamics and their impact. The report provides insights on global Cardiovascular & Soft Tissue Repair Patches market by application, raw material and major geographic regions. The report also covers basic technology development policies.

Key Players

The Cardiovascular & Soft Tissue Repair Patches market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are CryoLife, Edwards Life Sciences ; Baxter ; Admedus ; Bard Peripheral Vascular, Inc ; Terumo Cardiovascular: W.L. Gore & Associates; and Others.

One of the crucial factors that indicate the current market competitiveness is the increasing number of fusions and acquisitions by certain key players, such as Terumo Cardiovascular and Medtronic.